JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia.
Strobl K, Klufa J, Jin R, Artner-Gent L, Krauß D, Novoszel P, Strobl J, Stary G, Vujic I, Griss J, et al. EMBO Mol Med. 2024 Dec; 16(12):3142-3168. Epub 2024 Nov 9.